APABETALONE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE, TYPE 2 DIABETES, AND RECENT ACUTE CORONARY SYNDROME: A BETONMACE TRIAL REPORT

被引：0
|
作者：
Kalantar-Zadeh, Kamyar [2 ]
Nicholls, Stephen J. [3 ]
Buhr, Kevin A. [4 ]
Ginsburg, Henry N. [5 ]
Johansson, Jan
Kulikowski, Ewelina
Toth, Peter P. [6 ]
Wong, Norman [1 ]
Sweeney, Michael [1 ]
Schwartz, Gregory G. [7 ]
Ray, Kausik K. [8 ]
机构：
[1] Resverlogix Corp, San Francisco, CA USA
[2] Univ Calif Irvine, Irvine Sch Med, Irvine, CA USA
[3] Monash Univ, Melbourne, Australia
[4] Univ Wisconsin, Madison, WI USA
[5] Columbia Univ, New York, NY USA
[6] CGH Med Ctr, Sterling, IL USA
[7] Univ Colorado, Sch Med, Aurora, CO USA
[8] Imperial Coll Healthcare NHS Trust, London, England
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2020年 / 75卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：819 / 819
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF THE BET-INHIBITOR APABETALONE ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ACUTE CORONARY SYNDROME, ACCORDING TO PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE. A BETONMACE TRIAL REPORT
    Kalantar-Zadeh, Kam
    Ray, Kausik K.
    Nicholls, Stephen J.
    Ginsburg, Henry N.
    Buhr, Kevin A.
    Johansson, Jan
    Kulikowski, Ewelina
    Toth, Peter P.
    Sweeney, Michael
    Schwartz, Gregory G.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 182 - 182
  • [2] Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome Results from the BETonMACE Randomized Controlled Trial
    Kalantar-Zadeh, Kamyar
    Schwartz, Gregory G.
    Nicholls, Stephen J.
    Buhr, Kevin A.
    Ginsberg, Henry N.
    Johansson, Jan O.
    Kulikowski, Ewelina
    Lebioda, Kenneth
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Ray, Kausik K.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (05): : 705 - 716
  • [3] Reduction in the Risk of Major Adverse Cardiovascular Events With Apabetalone, a Bet Protein Inhibitor, in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes According to Insulin Treatment: Analysis of the Betonmace Trial
    Schwartz, Gregory G.
    Nicholls, Stephen J.
    Ginsberg, Henry
    Johansson, Jan
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Ray, Kausik K.
    [J]. CIRCULATION, 2020, 142
  • [4] Effect of BET Protein Inhibition With Apabetalone on Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Diabetes - Results of the BETonMACE Trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Ginsberg, Henry N.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Schwartz, Gregory G.
    [J]. CIRCULATION, 2019, 140 (25) : E966 - E966
  • [5] THE EPIGENETIC BET-INHIBITOR APABETALONE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES, ACUTE CORONARY SYNDROME AND AN ELEVATED ANGULO NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE - EXPLORATORY ANALYSIS OF THE BETONMACE TRIAL
    Toth, Peter P.
    Schwartz, Gregory G.
    Nicholls, Stephen J.
    Johansson, Jan
    Ginsberg, Henry
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Wong, Norman C.
    Szarek, Michael
    Sweeney, Michael
    Ray, Kausik Kumar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1104 - 1104
  • [6] Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Buhr, Kevin A.
    Ginsberg, Henry N.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Schwartz, Gregory G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1565 - 1573
  • [7] THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL
    Sweeney, Michael
    Nicholls, Stephen J.
    Ray, Kausik Kumar
    Buhr, Kevin
    Ginsberg, Henry
    Johansson, Jan
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter
    Wong, Norman
    Schwartz, Gregory G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 168 - 168
  • [8] Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome
    Cavender, Matthew A.
    White, William B.
    Liu, Yuyin
    Massaro, Joseph M.
    Bergenstal, Richard M.
    Mehta, Cyrus R.
    Zannad, Faiez
    Heller, Simon
    Cushman, William C.
    Cannon, Christopher P.
    [J]. CLINICAL CARDIOLOGY, 2018, 41 (08) : 1022 - 1027
  • [9] Total cardiovascular events analysis of the EXAMINE trial of patients with type 2 diabetes and recent acute coronary syndrome
    Cannon, C. P.
    Cavender, M. A.
    Liu, Y.
    Massaro, J. M.
    Bergenstal, R. M.
    Mehta, C. R.
    Zannad, F.
    White, W. B.
    [J]. DIABETOLOGIA, 2017, 60 : S530 - S531
  • [10] Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial
    Toth, P. P.
    Schwartz, G. G.
    Nicholls, S. J.
    Halliday, C.
    Ginsberg, H. N.
    Johansson, J. O.
    Kalantar-Zadeh, K.
    Kulikowski, E.
    Lebioda, K.
    Wong, N.
    Sweeney, M.
    Ray, K. K.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2536 - 2536
12345